Global Sterile Intravenous (IV) Solution Market Growth (Status and Outlook) 2025-2031
According to this study, the global Sterile Intravenous (IV) Solution market size will reach US$ million by 2031.
Sterile Intravenous (IV), also known as sterile Intravenous therapy is a therapy that delivers liquid which is in medical use into a vein.
United States market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sterile Intravenous (IV) Solution players cover B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Sterile Intravenous (IV) Solution Industry Forecast” looks at past sales and reviews total world Sterile Intravenous (IV) Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Sterile Intravenous (IV) Solution sales for 2025 through 2031. With Sterile Intravenous (IV) Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sterile Intravenous (IV) Solution industry.
This Insight Report provides a comprehensive analysis of the global Sterile Intravenous (IV) Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sterile Intravenous (IV) Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sterile Intravenous (IV) Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sterile Intravenous (IV) Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sterile Intravenous (IV) Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Intravenous (IV) Solution market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sterile Intravenous (IV), also known as sterile Intravenous therapy is a therapy that delivers liquid which is in medical use into a vein.
United States market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sterile Intravenous (IV) Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sterile Intravenous (IV) Solution players cover B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Sterile Intravenous (IV) Solution Industry Forecast” looks at past sales and reviews total world Sterile Intravenous (IV) Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Sterile Intravenous (IV) Solution sales for 2025 through 2031. With Sterile Intravenous (IV) Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sterile Intravenous (IV) Solution industry.
This Insight Report provides a comprehensive analysis of the global Sterile Intravenous (IV) Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sterile Intravenous (IV) Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sterile Intravenous (IV) Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sterile Intravenous (IV) Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sterile Intravenous (IV) Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Intravenous (IV) Solution market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Crystalloids
- Colloids
- Others
- Medications
- NutritionNutrition
- Blood-based Products
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun Medical Inc.
- Technoflex
- Baxter International
- ICU Medical, Inc
- Mckesson
- Amsino
- Wallcur
- Hebei Guangren Pharmaceutical Technology
- Jiangsu Hengfengqiang Biotechnology
- Hospira
- Jiangsu Hengfengqiang Biotechnology
- Hospira
- Xi'an Libang Alliance Enterprise Management
- Livzon Group
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sterile Intravenous (IV) Solution Market Size (2020-2031)
2.1.2 Sterile Intravenous (IV) Solution Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Sterile Intravenous (IV) Solution by Country/Region (2020, 2024 & 2031)
2.2 Sterile Intravenous (IV) Solution Segment by Type
2.2.1 Crystalloids
2.2.2 Colloids
2.2.3 Others
2.3 Sterile Intravenous (IV) Solution Market Size by Type
2.3.1 Sterile Intravenous (IV) Solution Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
2.4 Sterile Intravenous (IV) Solution Segment by Application
2.4.1 Medications
2.4.2 NutritionNutrition
2.4.3 Blood-based Products
2.4.4 Others
2.5 Sterile Intravenous (IV) Solution Market Size by Application
2.5.1 Sterile Intravenous (IV) Solution Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
3 STERILE INTRAVENOUS (IV) SOLUTION MARKET SIZE BY PLAYER
3.1 Sterile Intravenous (IV) Solution Market Size Market Share by Player
3.1.1 Global Sterile Intravenous (IV) Solution Revenue by Player (2020-2025)
3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by Player (2020-2025)
3.2 Global Sterile Intravenous (IV) Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 STERILE INTRAVENOUS (IV) SOLUTION BY REGION
4.1 Sterile Intravenous (IV) Solution Market Size by Region (2020-2025)
4.2 Global Sterile Intravenous (IV) Solution Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
4.4 APAC Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
4.5 Europe Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
4.6 Middle East & Africa Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
5.2 Americas Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
5.3 Americas Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sterile Intravenous (IV) Solution Market Size by Region (2020-2025)
6.2 APAC Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
6.3 APAC Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
7.2 Europe Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
7.3 Europe Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sterile Intravenous (IV) Solution by Region (2020-2025)
8.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
8.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL STERILE INTRAVENOUS (IV) SOLUTION MARKET FORECAST
10.1 Global Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.1.1 Global Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.1.2 Americas Sterile Intravenous (IV) Solution Forecast
10.1.3 APAC Sterile Intravenous (IV) Solution Forecast
10.1.4 Europe Sterile Intravenous (IV) Solution Forecast
10.1.5 Middle East & Africa Sterile Intravenous (IV) Solution Forecast
10.2 Americas Sterile Intravenous (IV) Solution Forecast by Country (2026-2031)
10.2.1 United States Market Sterile Intravenous (IV) Solution Forecast
10.2.2 Canada Market Sterile Intravenous (IV) Solution Forecast
10.2.3 Mexico Market Sterile Intravenous (IV) Solution Forecast
10.2.4 Brazil Market Sterile Intravenous (IV) Solution Forecast
10.3 APAC Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.3.1 China Sterile Intravenous (IV) Solution Market Forecast
10.3.2 Japan Market Sterile Intravenous (IV) Solution Forecast
10.3.3 Korea Market Sterile Intravenous (IV) Solution Forecast
10.3.4 Southeast Asia Market Sterile Intravenous (IV) Solution Forecast
10.3.5 India Market Sterile Intravenous (IV) Solution Forecast
10.3.6 Australia Market Sterile Intravenous (IV) Solution Forecast
10.4 Europe Sterile Intravenous (IV) Solution Forecast by Country (2026-2031)
10.4.1 Germany Market Sterile Intravenous (IV) Solution Forecast
10.4.2 France Market Sterile Intravenous (IV) Solution Forecast
10.4.3 UK Market Sterile Intravenous (IV) Solution Forecast
10.4.4 Italy Market Sterile Intravenous (IV) Solution Forecast
10.4.5 Russia Market Sterile Intravenous (IV) Solution Forecast
10.5 Middle East & Africa Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.5.1 Egypt Market Sterile Intravenous (IV) Solution Forecast
10.5.2 South Africa Market Sterile Intravenous (IV) Solution Forecast
10.5.3 Israel Market Sterile Intravenous (IV) Solution Forecast
10.5.4 Turkey Market Sterile Intravenous (IV) Solution Forecast
10.6 Global Sterile Intravenous (IV) Solution Forecast by Type (2026-2031)
10.7 Global Sterile Intravenous (IV) Solution Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Sterile Intravenous (IV) Solution Forecast
11 KEY PLAYERS ANALYSIS
11.1 B. Braun Medical Inc.
11.1.1 B. Braun Medical Inc. Company Information
11.1.2 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product Offered
11.1.3 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 B. Braun Medical Inc. Main Business Overview
11.1.5 B. Braun Medical Inc. Latest Developments
11.2 Technoflex
11.2.1 Technoflex Company Information
11.2.2 Technoflex Sterile Intravenous (IV) Solution Product Offered
11.2.3 Technoflex Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Technoflex Main Business Overview
11.2.5 Technoflex Latest Developments
11.3 Baxter International
11.3.1 Baxter International Company Information
11.3.2 Baxter International Sterile Intravenous (IV) Solution Product Offered
11.3.3 Baxter International Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Baxter International Main Business Overview
11.3.5 Baxter International Latest Developments
11.4 ICU Medical, Inc
11.4.1 ICU Medical, Inc Company Information
11.4.2 ICU Medical, Inc Sterile Intravenous (IV) Solution Product Offered
11.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ICU Medical, Inc Main Business Overview
11.4.5 ICU Medical, Inc Latest Developments
11.5 Mckesson
11.5.1 Mckesson Company Information
11.5.2 Mckesson Sterile Intravenous (IV) Solution Product Offered
11.5.3 Mckesson Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Mckesson Main Business Overview
11.5.5 Mckesson Latest Developments
11.6 Amsino
11.6.1 Amsino Company Information
11.6.2 Amsino Sterile Intravenous (IV) Solution Product Offered
11.6.3 Amsino Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Amsino Main Business Overview
11.6.5 Amsino Latest Developments
11.7 Wallcur
11.7.1 Wallcur Company Information
11.7.2 Wallcur Sterile Intravenous (IV) Solution Product Offered
11.7.3 Wallcur Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Wallcur Main Business Overview
11.7.5 Wallcur Latest Developments
11.8 Hebei Guangren Pharmaceutical Technology
11.8.1 Hebei Guangren Pharmaceutical Technology Company Information
11.8.2 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product Offered
11.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Hebei Guangren Pharmaceutical Technology Main Business Overview
11.8.5 Hebei Guangren Pharmaceutical Technology Latest Developments
11.9 Jiangsu Hengfengqiang Biotechnology
11.9.1 Jiangsu Hengfengqiang Biotechnology Company Information
11.9.2 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
11.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Jiangsu Hengfengqiang Biotechnology Main Business Overview
11.9.5 Jiangsu Hengfengqiang Biotechnology Latest Developments
11.10 Hospira
11.10.1 Hospira Company Information
11.10.2 Hospira Sterile Intravenous (IV) Solution Product Offered
11.10.3 Hospira Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Hospira Main Business Overview
11.10.5 Hospira Latest Developments
11.11 Jiangsu Hengfengqiang Biotechnology
11.11.1 Jiangsu Hengfengqiang Biotechnology Company Information
11.11.2 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
11.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Jiangsu Hengfengqiang Biotechnology Main Business Overview
11.11.5 Jiangsu Hengfengqiang Biotechnology Latest Developments
11.12 Hospira
11.12.1 Hospira Company Information
11.12.2 Hospira Sterile Intravenous (IV) Solution Product Offered
11.12.3 Hospira Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hospira Main Business Overview
11.12.5 Hospira Latest Developments
11.13 Xi'an Libang Alliance Enterprise Management
11.13.1 Xi'an Libang Alliance Enterprise Management Company Information
11.13.2 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product Offered
11.13.3 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Xi'an Libang Alliance Enterprise Management Main Business Overview
11.13.5 Xi'an Libang Alliance Enterprise Management Latest Developments
11.14 Livzon Group
11.14.1 Livzon Group Company Information
11.14.2 Livzon Group Sterile Intravenous (IV) Solution Product Offered
11.14.3 Livzon Group Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Livzon Group Main Business Overview
11.14.5 Livzon Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sterile Intravenous (IV) Solution Market Size (2020-2031)
2.1.2 Sterile Intravenous (IV) Solution Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Sterile Intravenous (IV) Solution by Country/Region (2020, 2024 & 2031)
2.2 Sterile Intravenous (IV) Solution Segment by Type
2.2.1 Crystalloids
2.2.2 Colloids
2.2.3 Others
2.3 Sterile Intravenous (IV) Solution Market Size by Type
2.3.1 Sterile Intravenous (IV) Solution Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
2.4 Sterile Intravenous (IV) Solution Segment by Application
2.4.1 Medications
2.4.2 NutritionNutrition
2.4.3 Blood-based Products
2.4.4 Others
2.5 Sterile Intravenous (IV) Solution Market Size by Application
2.5.1 Sterile Intravenous (IV) Solution Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
3 STERILE INTRAVENOUS (IV) SOLUTION MARKET SIZE BY PLAYER
3.1 Sterile Intravenous (IV) Solution Market Size Market Share by Player
3.1.1 Global Sterile Intravenous (IV) Solution Revenue by Player (2020-2025)
3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by Player (2020-2025)
3.2 Global Sterile Intravenous (IV) Solution Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 STERILE INTRAVENOUS (IV) SOLUTION BY REGION
4.1 Sterile Intravenous (IV) Solution Market Size by Region (2020-2025)
4.2 Global Sterile Intravenous (IV) Solution Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
4.4 APAC Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
4.5 Europe Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
4.6 Middle East & Africa Sterile Intravenous (IV) Solution Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
5.2 Americas Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
5.3 Americas Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sterile Intravenous (IV) Solution Market Size by Region (2020-2025)
6.2 APAC Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
6.3 APAC Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
7.2 Europe Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
7.3 Europe Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sterile Intravenous (IV) Solution by Region (2020-2025)
8.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2020-2025)
8.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL STERILE INTRAVENOUS (IV) SOLUTION MARKET FORECAST
10.1 Global Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.1.1 Global Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.1.2 Americas Sterile Intravenous (IV) Solution Forecast
10.1.3 APAC Sterile Intravenous (IV) Solution Forecast
10.1.4 Europe Sterile Intravenous (IV) Solution Forecast
10.1.5 Middle East & Africa Sterile Intravenous (IV) Solution Forecast
10.2 Americas Sterile Intravenous (IV) Solution Forecast by Country (2026-2031)
10.2.1 United States Market Sterile Intravenous (IV) Solution Forecast
10.2.2 Canada Market Sterile Intravenous (IV) Solution Forecast
10.2.3 Mexico Market Sterile Intravenous (IV) Solution Forecast
10.2.4 Brazil Market Sterile Intravenous (IV) Solution Forecast
10.3 APAC Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.3.1 China Sterile Intravenous (IV) Solution Market Forecast
10.3.2 Japan Market Sterile Intravenous (IV) Solution Forecast
10.3.3 Korea Market Sterile Intravenous (IV) Solution Forecast
10.3.4 Southeast Asia Market Sterile Intravenous (IV) Solution Forecast
10.3.5 India Market Sterile Intravenous (IV) Solution Forecast
10.3.6 Australia Market Sterile Intravenous (IV) Solution Forecast
10.4 Europe Sterile Intravenous (IV) Solution Forecast by Country (2026-2031)
10.4.1 Germany Market Sterile Intravenous (IV) Solution Forecast
10.4.2 France Market Sterile Intravenous (IV) Solution Forecast
10.4.3 UK Market Sterile Intravenous (IV) Solution Forecast
10.4.4 Italy Market Sterile Intravenous (IV) Solution Forecast
10.4.5 Russia Market Sterile Intravenous (IV) Solution Forecast
10.5 Middle East & Africa Sterile Intravenous (IV) Solution Forecast by Region (2026-2031)
10.5.1 Egypt Market Sterile Intravenous (IV) Solution Forecast
10.5.2 South Africa Market Sterile Intravenous (IV) Solution Forecast
10.5.3 Israel Market Sterile Intravenous (IV) Solution Forecast
10.5.4 Turkey Market Sterile Intravenous (IV) Solution Forecast
10.6 Global Sterile Intravenous (IV) Solution Forecast by Type (2026-2031)
10.7 Global Sterile Intravenous (IV) Solution Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Sterile Intravenous (IV) Solution Forecast
11 KEY PLAYERS ANALYSIS
11.1 B. Braun Medical Inc.
11.1.1 B. Braun Medical Inc. Company Information
11.1.2 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product Offered
11.1.3 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 B. Braun Medical Inc. Main Business Overview
11.1.5 B. Braun Medical Inc. Latest Developments
11.2 Technoflex
11.2.1 Technoflex Company Information
11.2.2 Technoflex Sterile Intravenous (IV) Solution Product Offered
11.2.3 Technoflex Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Technoflex Main Business Overview
11.2.5 Technoflex Latest Developments
11.3 Baxter International
11.3.1 Baxter International Company Information
11.3.2 Baxter International Sterile Intravenous (IV) Solution Product Offered
11.3.3 Baxter International Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Baxter International Main Business Overview
11.3.5 Baxter International Latest Developments
11.4 ICU Medical, Inc
11.4.1 ICU Medical, Inc Company Information
11.4.2 ICU Medical, Inc Sterile Intravenous (IV) Solution Product Offered
11.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ICU Medical, Inc Main Business Overview
11.4.5 ICU Medical, Inc Latest Developments
11.5 Mckesson
11.5.1 Mckesson Company Information
11.5.2 Mckesson Sterile Intravenous (IV) Solution Product Offered
11.5.3 Mckesson Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Mckesson Main Business Overview
11.5.5 Mckesson Latest Developments
11.6 Amsino
11.6.1 Amsino Company Information
11.6.2 Amsino Sterile Intravenous (IV) Solution Product Offered
11.6.3 Amsino Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Amsino Main Business Overview
11.6.5 Amsino Latest Developments
11.7 Wallcur
11.7.1 Wallcur Company Information
11.7.2 Wallcur Sterile Intravenous (IV) Solution Product Offered
11.7.3 Wallcur Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Wallcur Main Business Overview
11.7.5 Wallcur Latest Developments
11.8 Hebei Guangren Pharmaceutical Technology
11.8.1 Hebei Guangren Pharmaceutical Technology Company Information
11.8.2 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product Offered
11.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Hebei Guangren Pharmaceutical Technology Main Business Overview
11.8.5 Hebei Guangren Pharmaceutical Technology Latest Developments
11.9 Jiangsu Hengfengqiang Biotechnology
11.9.1 Jiangsu Hengfengqiang Biotechnology Company Information
11.9.2 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
11.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Jiangsu Hengfengqiang Biotechnology Main Business Overview
11.9.5 Jiangsu Hengfengqiang Biotechnology Latest Developments
11.10 Hospira
11.10.1 Hospira Company Information
11.10.2 Hospira Sterile Intravenous (IV) Solution Product Offered
11.10.3 Hospira Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Hospira Main Business Overview
11.10.5 Hospira Latest Developments
11.11 Jiangsu Hengfengqiang Biotechnology
11.11.1 Jiangsu Hengfengqiang Biotechnology Company Information
11.11.2 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
11.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Jiangsu Hengfengqiang Biotechnology Main Business Overview
11.11.5 Jiangsu Hengfengqiang Biotechnology Latest Developments
11.12 Hospira
11.12.1 Hospira Company Information
11.12.2 Hospira Sterile Intravenous (IV) Solution Product Offered
11.12.3 Hospira Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hospira Main Business Overview
11.12.5 Hospira Latest Developments
11.13 Xi'an Libang Alliance Enterprise Management
11.13.1 Xi'an Libang Alliance Enterprise Management Company Information
11.13.2 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product Offered
11.13.3 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Xi'an Libang Alliance Enterprise Management Main Business Overview
11.13.5 Xi'an Libang Alliance Enterprise Management Latest Developments
11.14 Livzon Group
11.14.1 Livzon Group Company Information
11.14.2 Livzon Group Sterile Intravenous (IV) Solution Product Offered
11.14.3 Livzon Group Sterile Intravenous (IV) Solution Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Livzon Group Main Business Overview
11.14.5 Livzon Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sterile Intravenous (IV) Solution Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sterile Intravenous (IV) Solution Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Crystalloids
Table 4. Major Players of Colloids
Table 5. Major Players of Others
Table 6. Sterile Intravenous (IV) Solution Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Table 9. Sterile Intravenous (IV) Solution Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Table 12. Global Sterile Intravenous (IV) Solution Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Sterile Intravenous (IV) Solution Revenue Market Share by Player (2020-2025)
Table 14. Sterile Intravenous (IV) Solution Key Players Head office and Products Offered
Table 15. Sterile Intravenous (IV) Solution Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Table 20. Global Sterile Intravenous (IV) Solution Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Sterile Intravenous (IV) Solution Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Sterile Intravenous (IV) Solution Market Size Market Share by Country (2020-2025)
Table 24. Americas Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Table 26. Americas Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Table 28. APAC Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Table 30. APAC Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Country (2020-2025)
Table 34. Europe Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Sterile Intravenous (IV) Solution
Table 40. Key Market Challenges & Risks of Sterile Intravenous (IV) Solution
Table 41. Key Industry Trends of Sterile Intravenous (IV) Solution
Table 42. Global Sterile Intravenous (IV) Solution Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Sterile Intravenous (IV) Solution Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Sterile Intravenous (IV) Solution Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Sterile Intravenous (IV) Solution Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. B. Braun Medical Inc. Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 47. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product Offered
Table 48. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. B. Braun Medical Inc. Main Business
Table 50. B. Braun Medical Inc. Latest Developments
Table 51. Technoflex Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 52. Technoflex Sterile Intravenous (IV) Solution Product Offered
Table 53. Technoflex Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Technoflex Main Business
Table 55. Technoflex Latest Developments
Table 56. Baxter International Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 57. Baxter International Sterile Intravenous (IV) Solution Product Offered
Table 58. Baxter International Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Baxter International Main Business
Table 60. Baxter International Latest Developments
Table 61. ICU Medical, Inc Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 62. ICU Medical, Inc Sterile Intravenous (IV) Solution Product Offered
Table 63. ICU Medical, Inc Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. ICU Medical, Inc Main Business
Table 65. ICU Medical, Inc Latest Developments
Table 66. Mckesson Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 67. Mckesson Sterile Intravenous (IV) Solution Product Offered
Table 68. Mckesson Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Mckesson Main Business
Table 70. Mckesson Latest Developments
Table 71. Amsino Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 72. Amsino Sterile Intravenous (IV) Solution Product Offered
Table 73. Amsino Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Amsino Main Business
Table 75. Amsino Latest Developments
Table 76. Wallcur Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 77. Wallcur Sterile Intravenous (IV) Solution Product Offered
Table 78. Wallcur Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Wallcur Main Business
Table 80. Wallcur Latest Developments
Table 81. Hebei Guangren Pharmaceutical Technology Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 82. Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product Offered
Table 83. Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Hebei Guangren Pharmaceutical Technology Main Business
Table 85. Hebei Guangren Pharmaceutical Technology Latest Developments
Table 86. Jiangsu Hengfengqiang Biotechnology Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 87. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
Table 88. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Jiangsu Hengfengqiang Biotechnology Main Business
Table 90. Jiangsu Hengfengqiang Biotechnology Latest Developments
Table 91. Hospira Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 92. Hospira Sterile Intravenous (IV) Solution Product Offered
Table 93. Hospira Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Hospira Main Business
Table 95. Hospira Latest Developments
Table 96. Jiangsu Hengfengqiang Biotechnology Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 97. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
Table 98. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Jiangsu Hengfengqiang Biotechnology Main Business
Table 100. Jiangsu Hengfengqiang Biotechnology Latest Developments
Table 101. Hospira Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 102. Hospira Sterile Intravenous (IV) Solution Product Offered
Table 103. Hospira Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Hospira Main Business
Table 105. Hospira Latest Developments
Table 106. Xi'an Libang Alliance Enterprise Management Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 107. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product Offered
Table 108. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Xi'an Libang Alliance Enterprise Management Main Business
Table 110. Xi'an Libang Alliance Enterprise Management Latest Developments
Table 111. Livzon Group Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 112. Livzon Group Sterile Intravenous (IV) Solution Product Offered
Table 113. Livzon Group Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Livzon Group Main Business
Table 115. Livzon Group Latest Developments
Table 1. Sterile Intravenous (IV) Solution Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sterile Intravenous (IV) Solution Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Crystalloids
Table 4. Major Players of Colloids
Table 5. Major Players of Others
Table 6. Sterile Intravenous (IV) Solution Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Table 9. Sterile Intravenous (IV) Solution Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Table 12. Global Sterile Intravenous (IV) Solution Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Sterile Intravenous (IV) Solution Revenue Market Share by Player (2020-2025)
Table 14. Sterile Intravenous (IV) Solution Key Players Head office and Products Offered
Table 15. Sterile Intravenous (IV) Solution Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Table 20. Global Sterile Intravenous (IV) Solution Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Sterile Intravenous (IV) Solution Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Sterile Intravenous (IV) Solution Market Size Market Share by Country (2020-2025)
Table 24. Americas Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Table 26. Americas Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Table 28. APAC Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Table 30. APAC Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Country (2020-2025)
Table 34. Europe Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Sterile Intravenous (IV) Solution
Table 40. Key Market Challenges & Risks of Sterile Intravenous (IV) Solution
Table 41. Key Industry Trends of Sterile Intravenous (IV) Solution
Table 42. Global Sterile Intravenous (IV) Solution Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Sterile Intravenous (IV) Solution Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Sterile Intravenous (IV) Solution Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Sterile Intravenous (IV) Solution Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. B. Braun Medical Inc. Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 47. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product Offered
Table 48. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. B. Braun Medical Inc. Main Business
Table 50. B. Braun Medical Inc. Latest Developments
Table 51. Technoflex Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 52. Technoflex Sterile Intravenous (IV) Solution Product Offered
Table 53. Technoflex Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Technoflex Main Business
Table 55. Technoflex Latest Developments
Table 56. Baxter International Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 57. Baxter International Sterile Intravenous (IV) Solution Product Offered
Table 58. Baxter International Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Baxter International Main Business
Table 60. Baxter International Latest Developments
Table 61. ICU Medical, Inc Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 62. ICU Medical, Inc Sterile Intravenous (IV) Solution Product Offered
Table 63. ICU Medical, Inc Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. ICU Medical, Inc Main Business
Table 65. ICU Medical, Inc Latest Developments
Table 66. Mckesson Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 67. Mckesson Sterile Intravenous (IV) Solution Product Offered
Table 68. Mckesson Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Mckesson Main Business
Table 70. Mckesson Latest Developments
Table 71. Amsino Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 72. Amsino Sterile Intravenous (IV) Solution Product Offered
Table 73. Amsino Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Amsino Main Business
Table 75. Amsino Latest Developments
Table 76. Wallcur Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 77. Wallcur Sterile Intravenous (IV) Solution Product Offered
Table 78. Wallcur Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Wallcur Main Business
Table 80. Wallcur Latest Developments
Table 81. Hebei Guangren Pharmaceutical Technology Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 82. Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product Offered
Table 83. Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Hebei Guangren Pharmaceutical Technology Main Business
Table 85. Hebei Guangren Pharmaceutical Technology Latest Developments
Table 86. Jiangsu Hengfengqiang Biotechnology Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 87. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
Table 88. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Jiangsu Hengfengqiang Biotechnology Main Business
Table 90. Jiangsu Hengfengqiang Biotechnology Latest Developments
Table 91. Hospira Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 92. Hospira Sterile Intravenous (IV) Solution Product Offered
Table 93. Hospira Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Hospira Main Business
Table 95. Hospira Latest Developments
Table 96. Jiangsu Hengfengqiang Biotechnology Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 97. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Offered
Table 98. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Jiangsu Hengfengqiang Biotechnology Main Business
Table 100. Jiangsu Hengfengqiang Biotechnology Latest Developments
Table 101. Hospira Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 102. Hospira Sterile Intravenous (IV) Solution Product Offered
Table 103. Hospira Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Hospira Main Business
Table 105. Hospira Latest Developments
Table 106. Xi'an Libang Alliance Enterprise Management Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 107. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product Offered
Table 108. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Xi'an Libang Alliance Enterprise Management Main Business
Table 110. Xi'an Libang Alliance Enterprise Management Latest Developments
Table 111. Livzon Group Details, Company Type, Sterile Intravenous (IV) Solution Area Served and Its Competitors
Table 112. Livzon Group Sterile Intravenous (IV) Solution Product Offered
Table 113. Livzon Group Sterile Intravenous (IV) Solution Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Livzon Group Main Business
Table 115. Livzon Group Latest Developments
LIST OF FIGURES
Figure 1. Sterile Intravenous (IV) Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sterile Intravenous (IV) Solution Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sterile Intravenous (IV) Solution Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sterile Intravenous (IV) Solution Sales Market Share by Country/Region (2024)
Figure 8. Sterile Intravenous (IV) Solution Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sterile Intravenous (IV) Solution Market Size Market Share by Type in 2024
Figure 10. Sterile Intravenous (IV) Solution in Medications
Figure 11. Global Sterile Intravenous (IV) Solution Market: Medications (2020-2025) & ($ millions)
Figure 12. Sterile Intravenous (IV) Solution in NutritionNutrition
Figure 13. Global Sterile Intravenous (IV) Solution Market: NutritionNutrition (2020-2025) & ($ millions)
Figure 14. Sterile Intravenous (IV) Solution in Blood-based Products
Figure 15. Global Sterile Intravenous (IV) Solution Market: Blood-based Products (2020-2025) & ($ millions)
Figure 16. Sterile Intravenous (IV) Solution in Others
Figure 17. Global Sterile Intravenous (IV) Solution Market: Others (2020-2025) & ($ millions)
Figure 18. Global Sterile Intravenous (IV) Solution Market Size Market Share by Application in 2024
Figure 19. Global Sterile Intravenous (IV) Solution Revenue Market Share by Player in 2024
Figure 20. Global Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Figure 21. Americas Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 22. APAC Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 23. Europe Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 25. Americas Sterile Intravenous (IV) Solution Value Market Share by Country in 2024
Figure 26. United States Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Region in 2024
Figure 31. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Figure 32. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Figure 33. China Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 37. India Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Country in 2024
Figure 40. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Figure 41. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Figure 42. Germany Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 43. France Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 56. APAC Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 57. Europe Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 59. United States Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 60. Canada Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 61. Mexico Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 62. Brazil Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 63. China Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 64. Japan Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 65. Korea Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 67. India Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 68. Australia Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 69. Germany Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 70. France Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 71. UK Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 72. Italy Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 73. Russia Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 74. Egypt Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 75. South Africa Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 76. Israel Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 77. Turkey Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 78. Global Sterile Intravenous (IV) Solution Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Sterile Intravenous (IV) Solution Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 1. Sterile Intravenous (IV) Solution Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sterile Intravenous (IV) Solution Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sterile Intravenous (IV) Solution Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sterile Intravenous (IV) Solution Sales Market Share by Country/Region (2024)
Figure 8. Sterile Intravenous (IV) Solution Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sterile Intravenous (IV) Solution Market Size Market Share by Type in 2024
Figure 10. Sterile Intravenous (IV) Solution in Medications
Figure 11. Global Sterile Intravenous (IV) Solution Market: Medications (2020-2025) & ($ millions)
Figure 12. Sterile Intravenous (IV) Solution in NutritionNutrition
Figure 13. Global Sterile Intravenous (IV) Solution Market: NutritionNutrition (2020-2025) & ($ millions)
Figure 14. Sterile Intravenous (IV) Solution in Blood-based Products
Figure 15. Global Sterile Intravenous (IV) Solution Market: Blood-based Products (2020-2025) & ($ millions)
Figure 16. Sterile Intravenous (IV) Solution in Others
Figure 17. Global Sterile Intravenous (IV) Solution Market: Others (2020-2025) & ($ millions)
Figure 18. Global Sterile Intravenous (IV) Solution Market Size Market Share by Application in 2024
Figure 19. Global Sterile Intravenous (IV) Solution Revenue Market Share by Player in 2024
Figure 20. Global Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Figure 21. Americas Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 22. APAC Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 23. Europe Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Sterile Intravenous (IV) Solution Market Size 2020-2025 ($ millions)
Figure 25. Americas Sterile Intravenous (IV) Solution Value Market Share by Country in 2024
Figure 26. United States Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Region in 2024
Figure 31. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Figure 32. APAC Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Figure 33. China Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 37. India Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Country in 2024
Figure 40. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Figure 41. Europe Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Figure 42. Germany Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 43. France Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Sterile Intravenous (IV) Solution Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 56. APAC Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 57. Europe Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 59. United States Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 60. Canada Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 61. Mexico Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 62. Brazil Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 63. China Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 64. Japan Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 65. Korea Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 67. India Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 68. Australia Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 69. Germany Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 70. France Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 71. UK Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 72. Italy Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 73. Russia Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 74. Egypt Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 75. South Africa Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 76. Israel Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 77. Turkey Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
Figure 78. Global Sterile Intravenous (IV) Solution Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Sterile Intravenous (IV) Solution Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Sterile Intravenous (IV) Solution Market Size 2026-2031 ($ millions)
More Publications
Global Meningococcal Infections Treatment Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
79 pages
Global Bacillus Coagulans Market Growth 2025-2031
US$ 3,660.00
April 2025
87 pages
Global Dermatitis Drugs Market Growth 2025-2031
US$ 3,660.00
December 2025
93 pages
Global Calcium Folinate Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
104 pages
